drugset / Trial / NCT04766853
Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is a prospective, randomized pilot study. To verify an efficacy and safety of the Intratympanic drug delivery vehicle, patients who have not responded to the existing standard treatment will be enrolled. Hearing test, endoscopy of tympanic membrane and CT scans will be conducted after intratympanic treatment for evaluation.
Timeline
- Start
- 2021-07-22
- Primary completion
- 2023-04-18
- Completion
- 2024-07-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 5 mg/ml | Other |
| Subject | Hyaluronic Acid | Other / unclassified | 20 mg | Other |